CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 43 enrolled
Drug / intervention
Vitamin B6 100 MG +1 moredrug
Likely dose
Vitamin B6 100 MGfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06415383
NCT06415383Phase 1Completed
CompareCT.gov

Testing the Effects of High-dose Vitamin B6 Supplements on Pain Thresholds and Tolerance in Healthy Adults

University of Reading·interventional·Posted May 16, 2024·Updated Mar 11, 2026

In Brief

A Phase 1 clinical trial evaluating Vitamin B6 100 MG and Placebo for Pain. Completed, enrolled 43 participants across 1 site.

Detailed Summary

This clinical trial aims to explore the effect of Vitamin B6 supplementation on pain thresholds and tolerance in healthy adults using thermal and electrical stimulation. Researchers will compare a placebo group to high-dose Vitamin-B6 to see if vitamin B6 increases pain thresholds and tolerance.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited Kingdom
CollaboratorsINNOPURE

Timeline

Phase 1CompletedFinished
20252026
First PostedMay 16, 2024
Enrollment StartMay 30, 2024
Primary CompletionMar 1, 2025
Study CompletionJun 30, 2025
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 2.1 years ago

Interventions

Vitamin B6 100 MGdrug

Vitamin B6 in for the form of pyridoxal phosphate (PLP)

Placeboother

Placebo tablet containing microcrystalline cellulose